Paying users zone. Data is covered by .

  • Get to Abbott Laboratories for $17.99, or

  • get to whole website for at least 3 months from $49.99.

 

$17.99


Economic Profit

Abbott Laboratories, economic profit calculation

USD $ in millions

 
12 months ended Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Net operating profit after taxes (NOPAT)1
Cost of capital2 % % % % %
Invested capital3
Economic profit4

Source: Based on data from Abbott Laboratories Annual Reports

2017 Calculations

1 NOPAT. See Details »

2 Cost of capital. See Details »

3 Invested capital. See Details »

4 Economic profit = NOPAT – Cost of capital × Invested capital
= % × =

Item Description The company
Economic profit Economic profit is a measure of corporate performance computed by taking the spread between the return on invested capital and the cost of capital, and multiplying by the invested capital. Abbott Laboratories's economic profit declined from 2015 to 2016 and from 2016 to 2017.

Top


Net Operating Profit after Taxes (NOPAT)

Abbott Laboratories, NOPAT calculation

USD $ in millions

 
12 months ended Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Net earnings
Deferred income tax expense (benefit)1
Increase (decrease) in allowances for doubtful accounts and product returns2
Increase (decrease) in restructuring Plans, accrued balance3
Increase (decrease) in equity equivalents4
Interest expense
Interest expense, operating lease obligations5
Adjusted interest expense
Tax benefit of interest expense6
Adjusted interest expense, after taxes7
(Gain) loss on marketable securities
Interest income
Investment income, before taxes
Tax expense (benefit) of investment income8
Investment income, after taxes9
(Income) loss from discontinued operations, net of tax10
Net operating profit after taxes (NOPAT)

Source: Based on data from Abbott Laboratories Annual Reports

2017 Calculations

1 Elimination of deferred tax expense. See Details »

2 Addition of increase (decrease) in allowances for doubtful accounts and product returns.

3 Addition of increase (decrease) in restructuring Plans, accrued balance.

4 Addition of increase (decrease) in equity equivalents to net earnings.

5 Interest expense on capitalized operating leases = PV of operating lease payments × Discount rate
= × % =

6 Tax benefit of interest expense = Adjusted interest expense × Statutory income tax rate
= × 35% =

7 Addition of after taxes interest expense to net earnings.

8 Tax expense (benefit) of investment income = Investment income, before tax × Statutory income tax rate
= × 35% =

9 Elimination of after taxes investment income.

10 Elimination of discontinued operations.

Item Description The company
NOPAT Net operating profit after taxes is income from operations, but after removement of taxes calculated on cash basis that are relevant to operating income. Abbott Laboratories's NOPAT declined from 2015 to 2016 and from 2016 to 2017.

Top


Cash Operating Taxes

Abbott Laboratories, cash operating taxes calculation

USD $ in millions

 
12 months ended Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Taxes on earnings from continuing operations
Less: Deferred income tax expense (benefit)
Add: Tax savings from interest expense
Less: Tax imposed on investment income
Cash operating taxes

Source: Based on data from Abbott Laboratories Annual Reports

Item Description The company
Cash operating taxes Cash operating taxes are estimated by adjusting income tax expense for changes in deferred taxes and tax benefit from the interest deduction. Abbott Laboratories's cash operating taxes increased from 2015 to 2016 and from 2016 to 2017.

Top


Invested Capital

Abbott Laboratories, invested capital calculation (financing approach)

USD $ in millions

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Short-term borrowings
Current portion of long-term debt
Long-term debt, excluding current portion
PV of operating lease payments1
Total reported debt & leases
Total Abbott shareholders' investment
Net deferred tax (assets) liabilities2
Allowances for doubtful accounts and product returns3
Restructuring Plans, accrued balance4
Equity equivalents5
Accumulated other comprehensive (income) loss, net of tax6
Noncontrolling interests in subsidiaries
Adjusted total Abbott shareholders' investment
Construction in progress7
Marketable securities8
Invested capital

Source: Based on data from Abbott Laboratories Annual Reports

1 Addition of capitalized operating leases. See Details »

2 Elimination of deferred taxes from assets and liabilities. See Details »

3 Addition of allowance for doubtful accounts receivable.

4 Addition of restructuring Plans, accrued balance.

5 Addition of equity equivalents to total Abbott shareholders' investment.

6 Removal of accumulated other comprehensive income.

7 Subtraction of construction in progress.

8 Subtraction of marketable securities.

Item Description The company
Invested capital Capital is an approximation of the economic book value of all cash invested in going-concern business activities. Abbott Laboratories's invested capital increased from 2015 to 2016 and from 2016 to 2017.

Top


Cost of Capital

Abbott Laboratories, cost of capital calculations

Fair Value1 Weights Cost of Capital
Equity2 ÷ = × % = %
Debt3 ÷ = × % × (1 – 35%) = %
PV of operating lease payments4 ÷ = × % × (1 – 35%) = %
Total: %

Source: Based on data from Abbott Laboratories Annual Reports

1 USD $ in millions

2 Equity. See Details »

3 Debt. See Details »

4 PV of operating lease payments. See Details »

Fair Value1 Weights Cost of Capital
Equity2 ÷ = × % = %
Debt3 ÷ = × % × (1 – 35%) = %
PV of operating lease payments4 ÷ = × % × (1 – 35%) = %
Total: %

Source: Based on data from Abbott Laboratories Annual Reports

1 USD $ in millions

2 Equity. See Details »

3 Debt. See Details »

4 PV of operating lease payments. See Details »

Fair Value1 Weights Cost of Capital
Equity2 ÷ = × % = %
Debt3 ÷ = × % × (1 – 35%) = %
PV of operating lease payments4 ÷ = × % × (1 – 35%) = %
Total: %

Source: Based on data from Abbott Laboratories Annual Reports

1 USD $ in millions

2 Equity. See Details »

3 Debt. See Details »

4 PV of operating lease payments. See Details »

Fair Value1 Weights Cost of Capital
Equity2 ÷ = × % = %
Debt3 ÷ = × % × (1 – 35%) = %
PV of operating lease payments4 ÷ = × % × (1 – 35%) = %
Total: %

Source: Based on data from Abbott Laboratories Annual Reports

1 USD $ in millions

2 Equity. See Details »

3 Debt. See Details »

4 PV of operating lease payments. See Details »

Fair Value1 Weights Cost of Capital
Equity2 ÷ = × % = %
Debt3 ÷ = × % × (1 – 35%) = %
PV of operating lease payments4 ÷ = × % × (1 – 35%) = %
Total: %

Source: Based on data from Abbott Laboratories Annual Reports

1 USD $ in millions

2 Equity. See Details »

3 Debt. See Details »

4 PV of operating lease payments. See Details »

Top


Economic Spread

Abbott Laboratories, economic spread calculation

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Economic profit1
Invested capital2
Ratio
Economic spread3 % % % % %

Source: Based on data from Abbott Laboratories Annual Reports

2017 Calculations

1 Economic profit. See Details »

2 Invested capital. See Details »

3 Economic spread = 100 × Economic profit ÷ Invested capital
= 100 × ÷ = %

Ratio Description The company
Economic spread The ratio of economic profit to invested capital, also equal to the difference between return on invested capital (ROIC) and cost of capital. Abbott Laboratories's economic spread deteriorated from 2015 to 2016 and from 2016 to 2017.

Top


Economic Profit Margin

Abbott Laboratories, economic profit margin calculation

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Economic profit1
Net sales
Ratio
Economic profit margin2 % % % % %

Source: Based on data from Abbott Laboratories Annual Reports

2017 Calculations

1 Economic profit. See Details »

2 Economic profit margin = 100 × Economic profit ÷ Net sales
= 100 × ÷ = %

Ratio Description The company
Economic profit margin The ratio of economic profit to sales. It is the company's profit margin covering income efficiency and asset management. Economic profit margin is not biased in favor of capital-intensive business models, because any added capital is a cost to the economic profit margin. Abbott Laboratories's economic profit margin deteriorated from 2015 to 2016 and from 2016 to 2017.

Top